ACNV.US Accelera Innovations Inc
- Market cap
- USD 8.14K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2022.
Is ACNV.US undervalued?
Graham numberThe Graham number of Accelera Innovations Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Accelera Innovations Inc fundamental analysis
No fundamental analysis for Accelera Innovations Inc yet.
Accelera Innovations Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Accelera Innovations Inc
Accelera Innovations, Inc., a healthcare service company, focuses on the development of Internet-based software in the United States. The company's Accelera Technology, an Internet-based software platform enhances the functionality and performance of healthcare services through making clinical healthcare data available to healthcare consumers. It also provides billing, practice management, and administrative services to doctors and other clinicians, as well as home health se…
Full company profileAccelera Innovations Inc financial statements
Accelera Innovations Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | - | 376K | 2.72M | 3.62M | 2.75K | - | - | - | - |
| Gross Profit | - | - | 376K | 1.03M | 1.77M | 2.75K | - | - | - | - |
| Operating Income | -158K | -5.11M | -7.26M | -31.8M | -13.1M | -1.90M | - | - | - | - |
| EBITDA | -158K | -5.11M | -7.26M | -31.9M | -13.0M | -1.48M | - | - | - | - |
| Net Income | -158K | -5.11M | -7.40M | -36.3M | -14.9M | -1.93M | - | - | - | - |
| EPS | -0.01 | -0.24 | -0.34 | -1.13 | -0.35 | -0.04 | - | - | - | - |
| Balance Sheet | ||||||||||
| Total Assets | 5.87K | 5.87K | 5.97M | 784K | 515K | 9.64K | - | - | - | - |
| Total Liabilities | - | - | 6.43M | 6.50M | 6.92M | 2.39M | - | - | - | - |
| Shareholders' Equity | - | 5.87K | -463K | -5.72M | -6.40M | -2.38M | - | - | - | - |
| Cash & Short-term Investments | 5.87K | 5.87K | 186K | 54.9K | 475K | 0.00 | - | - | - | - |
| Total Debt | - | - | 5.98M | 5.39M | 5.47M | 1.04M | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -163K | -114K | -1.18M | -2.11M | -29.2K | -215K | - | - | - | - |
| Capital Expenditure | 0.00 | 0.00 | 3.77K | 3.77K | 3.77K | 3.77K | - | - | - | - |
| Free Cash Flow | -163K | -114K | -1.18M | -2.11M | -33.0K | -215K | - | - | - | - |
| Ratios | ||||||||||
| ROE | - | -87,054.5% | - | - | - | - | - | - | - | - |
| ROA | -2,697.3% | -87,054.5% | -124.0% | -4,628.5% | -2,897.7% | -19,974.0% | - | - | - | - |
| Net Profit Margin | - | - | -1,969.4% | -1,337.1% | -411.9% | -70,010.7% | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Accelera Innovations Inc dividends
Accelera Innovations Inc has not paid dividends in the last 7 fiscal years.
Who owns Accelera Innovations Inc
Ownership data of Accelera Innovations Inc is not available yet.
Accelera Innovations Inc company profile
- Company name
- Accelera Innovations Inc
- Ticker
- ACNV.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- December
- Address
- 6039 Thurber Drive, Colorado Springs, CO, United States, 80924
- Phone
- 866 920 0758
- Website
- accelerainnovations.com
About Accelera Innovations Inc
Accelera Innovations, Inc., a healthcare service company, focuses on the development of Internet-based software in the United States. The company's Accelera Technology, an Internet-based software platform enhances the functionality and performance of healthcare services through making clinical healthcare data available to healthcare consumers. It also provides billing, practice management, and administrative services to doctors and other clinicians, as well as home health services to patients in Chicago. The company was formerly known as Accelerated Acquisitions IV, Inc. and changed its name to Accelera Innovations, Inc. in October 2011. Accelera Innovations, Inc. was founded in 2008 and is based in Colorado Springs, Colorado.
Accelera Innovations Inc management
2- Mr. Geoffrey J. ThompsonInterim CEO & CFO · born 1968
- Mr. Patrick CustardoChief Acquisitions Officer · born 1952